The DOI matches its Crossref record; 55 of the 55 references it cites were found in a registry or an index.
Prevalence and Predictors of Risk for Type 2 Diabetes Mellitus and Impaired Glucose Tolerance in Polycystic Ovary Syndrome: A Prospective, Controlled Study in 254 Affected Women
Open accessAbstract
Women with polycystic ovary syndrome (PCOS) are insulin resistant, have insulin secretory defects, and are at high risk for glucose intolerance. We performed this study to determine the prevalence of glucose intolerance and parameters associated with risk for this in PCOS women. Two-hundred and fifty-four PCOS women, aged 14-44 yr, were prospectively evaluated at 2 centers, 1 urban and ethnically diverse (n = 110) and 1 rural and ethnically homogeneous (n = 144). The rural PCOS women were compared to 80 control women of similar weight, ethnicity, and age. A 75-g oral glucose challenge was administered after a 3-day 300-g carbohydrate diet and an overnight fast with 0 and 2 h blood samples for glucose levels. Diabetes was categorized according to WHO criteria. The prevalence of glucose intolerance was 31.1% impaired glucose intolerance (IGT) and 7.5% diabetes. In nonobese PCOS women (body mass index, <27 kg/m2), 10.3% IGT and 1.5% diabetes were found. The prevalence of glucose intolerance was significantly higher in PCOS vs. control women (chi2 = 7.0; P = 0.01; odds ratio = 2.76; 95% confidence interval = 1.23-6.57). Variables most associated with postchallenge glucose levels were fasting glucose levels (P < 0.0001), PCOS status (P = 0.002), waist/hip ratio (P = 0.01), and body mass index (P = 0.021). The American Diabetes Association criteria applied to fasting glucose significantly underdiagnosed diabetes compared to the WHO criteria (3.2% vs. 7.5%; chi2 = 4.7; P = 0.046; odds ratio = 2.48; 95% confidence interval = 1.01-6.69). We conclude that 1) PCOS women are at significantly increased risk for IGT and type 2 diabetes mellitus at all weights and at a young age; 2) these prevalence rates are similar in 2 different populations of PCOS women, suggesting that PCOS may be a more important risk factor than ethnicity or race for glucose intolerance in young women; and 3) the American Diabetes Association diabetes diagnostic criteria failed to detect a significant number of PCOS women with diabetes by postchallenge glucose values.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“As such, women with PCOS exhibit increased risk of impaired glucose tolerance and T2DM regardless of weight and age [20].”
From Exercise, or exercise and diet for the management of polycystic ovary syndrome: a systematic review and meta-analysis (2019) · cites this paper as [20]
In the citing paper
“Approximately 50–70% of women with PCOS have IR and hyperinsulinaemia [128], whereas many also present evidence of glucose intolerance [20].”
From Exercise, or exercise and diet for the management of polycystic ovary syndrome: a systematic review and meta-analysis (2019) · cites this paper as [20]
In the citing paper
“In women with PCOS, dysglycemia typically consists of impaired glucose tolerance [12], its prevalence being of almost 30% in both adult women [13] and affected adolescents [14].”
From From Prediabetes to Type 2 Diabetes Mellitus in Women with Polycystic Ovary Syndrome: Lifestyle and Pharmacological Management (2020) · cites this paper as [12]
In the citing paper
“PCOS patients commonly have metabolic complications, such as type 2 diabetes, insulin resistance (IR), and adipose tissue dysfunction (7–9).”
From Circulating Adipokine Levels in Nonobese Women with Polycystic Ovary Syndrome and in Nonobese Control Women: A Systematic Review and Meta-Analysis (2021) · cites this paper as [7]
In the citing paper
“However, women with PCOS generally have hyperandrogenism and lower SHBG [52] and differences at the end of the intervention are again likely related to baseline differences.”
From Weight management interventions in women with and without PCOS: a systematic review (2017) · cites this paper as [52]
In the citing paper
“However, women with PCOS generally have hyperandrogenism and lower SHBG [52] and differences at the end of the intervention are again likely related to baseline differences.”
From Weight management interventions in women with and without PCOS: a systematic review (2017) · cites this paper as [52]
In the citing paper
“In PCOS, other novel CVD risk factors, premature cardiovascular dysfunction and subclinical CVD 29,30,83 have been noted and are related to IR and obesity. 84-89”
From Assessment and management of polycystic ovary syndrome: Summary of an evidence-based guideline (2011) · cites this paper as [85]
Citations
Cites
The publisher hasn’t deposited this paper’s reference list.
Cited by
Sorted by citations
Items 301–400 of 1,388
Role of lifestyle modification in the management of polycystic ovary syndrome
Hoeger, K. M. (2006) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2006.03.008 · Cited by 98
Kamenov, Z., & Gateva, A. (2020) · Molecules · doi:10.3390/molecules25235566 · Cited by 100
Metformin therapy for the reproductive and metabolic consequences of polycystic ovary syndrome
Sam, S., & Ehrmann, D. A. (2017) · Diabetologia · doi:10.1007/s00125-017-4306-3 · Cited by 93
Polycystic ovary syndrome and autoimmunity
Petríková, J., Lazúrová, I., & Shoenfeld, Y. (2010) · European Journal of Internal Medicine · doi:10.1016/j.ejim.2010.06.008 · Cited by 94
Gender Differences and Cardiometabolic Risk: The Importance of the Risk Factors
Meloni, A., Dessalvi, C. C., Cugusi, L., Donataccio, M. P., Deidda, M., Sciomer, S., Gallina, S., Vassalle, C., Moscucci, F., Mercuro, G., et al. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24021588 · Cited by 108
Zhang, H. Y., Guo, C. X., Zhu, F. F., Qu, P. P., Lin, W. J., & Xiong, J. (2013) · Archives of Gynecology and Obstetrics · doi:10.1007/s00404-012-2568-z · Cited by 94
Genetics of Polycystic Ovary Syndrome
Barber, T. M., & Franks, S. (2012) · Frontiers of hormone research · doi:10.1159/000341682 · Cited by 98
Obesity and reproduction: an educational bulletin
(2008) · Fertility and Sterility · doi:10.1016/j.fertnstert.2008.08.005 · Cited by 91
The effect of polycystic ovary syndrome on health-related quality of life
Coffey, S., & Mason, H. (2003) · Gynecological Endocrinology · doi:10.1080/09513590312331290268 · Cited by 94
Adipose tissue and reproduction in women
BOHLER, H. C. L., Mokshagundam, S. L., & Winters, S. J. (2009) · Fertility and Sterility · doi:10.1016/j.fertnstert.2009.03.079 · Cited by 96
Polycystic Ovary Syndrome: Diagnosis and Treatment
Setji, T. L., & Brown, A. J. (2007) · The American Journal of Medicine · doi:10.1016/j.amjmed.2006.06.029 · Cited by 91
Allen, H. F., Mazzoni, C., Heptulla, R. A., Murray, M. A., Miller, N., Koenigs, L., & Reiter, E. O. (2005) · Journal of Pediatric Endocrinology and Metabolism · doi:10.1515/jpem.2005.18.8.761 · Cited by 90
Nawaz, F. H., Khalid, R., Naru, T. Y., & Rizvi, J. (2008) · Journal of obstetrics and gynaecology research · doi:10.1111/j.1447-0756.2008.00856.x · Cited by 91
Mukherjee, S., Shaikh, N. J., Khavale, S., Shinde, G., Meherji, P. K., Shah, N. S., & Maitra, A. (2009) · European Journal of Endocrinology · doi:10.1530/eje-08-0932 · Cited by 94
Norman, R. J., Wu, R., & Stankiewicz, M. T. (2004) · The Medical Journal of Australia · doi:10.5694/j.1326-5377.2004.tb05838.x · Cited by 93
Zulian, E., Sartorato, P., Benedini, S., Baro, G., Armanini, D., Mantero, F., & Scaroni, C. M. (2005) · Journal of Endocrinological Investigation · doi:10.1007/bf03345529 · Cited by 91
Fan, P., Liu, H., Wang, Y., Zhang, F., & Bai, H. (2011) · Reproductive BioMedicine Online · doi:10.1016/j.rbmo.2011.10.010 · Cited by 90
Menstrual Cycle Irregularity and Metabolic Disorders: A Population-Based Prospective Study
Dovom, M. R., Tehrani, F. R., Djalalinia, S., Cheraghi, L., Behboudi‐Gandevani, S., & Azizi, F. (2016) · PLoS ONE · doi:10.1371/journal.pone.0168402 · Cited by 90
Bañuls, C., Rovira‐Llopis, S., Marañón, A., Veses, S., Jover, A., Gomez, M., Rocha, M., Hernández‐Mijares, A., & Víctor, V. M. (2017) · Metabolism · doi:10.1016/j.metabol.2017.02.012 · Cited by 90
Pathogenesis of polycystic ovary syndrome: what is the role of obesity?
Salehi, M., Bravo-Vera, R., Sheikh, A., Gouller, A., & Poretsky, L. (2004) · Metabolism · doi:10.1016/j.metabol.2003.10.005 · Cited by 90
A practical approach to the diagnosis of polycystic ovary syndrome
Chang, R. J. (2004) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2004.04.045 · Cited by 89
Li, S., Chu, Q., Ma, J., Sun, Y. W., Tao, T., Huang, R., Liao, Y., Yue, J., Zheng, J., Wang, L., et al. (2016) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2016-2692 · Cited by 93
Trolle, B., Flyvbjerg, A., Kesmodel, U., & Lauszus, F. F. (2007) · Human Reproduction · doi:10.1093/humrep/dem271 · Cited by 91
Rasmussen, C. B., & Lindenberg, S. (2014) · Frontiers in Endocrinology · doi:10.3389/fendo.2014.00140 · Cited by 90
Hu, Y., Wen, S., Yuan, D., Peng, L., Zeng, R., Yang, Z., Liu, Q., Xu, L., & Kang, D. (2017) · Gynecological Endocrinology · doi:10.1080/09513590.2017.1405931 · Cited by 95
Xita, N. V., Georgiou, I. A., Chatzikyriakidou, A., Vounatsou, M., Papassotiriou, G.-P., Papassotiriou, I., & Tsatsoulis, A. A. (2005) · Clinical Chemistry · doi:10.1373/clinchem.2004.043109 · Cited by 92
Hara, M., Alcoser, S. Y., Qaadir, A., Beiswenger, K. K., Cox, N. J., & Ehrmann, D. A. (2002) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.87.2.8255 · Cited by 89
Mechanisms IN endocrinology: metabolic syndrome through the female life cycle
Vryonidou, A., Paschou, S. A., Muscogiuri, G., Orio, F., & Goulis, D. G. (2015) · European Journal of Endocrinology · doi:10.1530/eje-15-0275 · Cited by 88
Prevalence and risk of depressive disorders in women with polycystic ovary syndrome (PCOS)
Bhattacharya, S. M., & Jha, A. (2010) · Fertility and Sterility · doi:10.1016/j.fertnstert.2009.09.025 · Cited by 88
Liu, A. L., Xie, H. J., Xie, H. Y., Liu, J., Yin, J., Hu, J. S., & Peng, C. Y. (2017) · BMC Medical Genetics · doi:10.1186/s12881-017-0452-1 · Cited by 88
Obesity and the Polycystic Ovary Syndrome
Magnotti, M., & Futterweit, W. (2007) · Medical Clinics of North America · doi:10.1016/j.mcna.2007.06.010 · Cited by 86
Obesity Differentially Affects Phenotypes of Polycystic Ovary Syndrome
Moran, C., Arriaga, M., Rodriguez, G., & Moran, S. (2012) · International Journal of Endocrinology · doi:10.1155/2012/317241 · Cited by 86
Increased plasma visfatin concentrations in women with polycystic ovary syndrome
Chan, T., Chen, Y., Chen, H.-H., Lee, C., Jong, S., & Tsai, E. (2007) · Fertility and Sterility · doi:10.1016/j.fertnstert.2006.11.120 · Cited by 87
Insulin Resistance and Impaired Insulin Secretion in Prenatally Androgenized Male Rhesus Monkeys
Bruns, C. M., Baum, S. T., Colman, R. J., Eisner, J. R., Kemnitz, J. W., Weindruch, R. H., & Abbott, D. H. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2004-0918 · Cited by 87
Jensterle, M., Kocjan, T., Kravos, N. A., Pfeifer, M., & Janez, A. (2015) · Endocrine Research · doi:10.3109/07435800.2014.966385 · Cited by 86
Fan, P., Liu, H., Wang, X., Zhang, F., Song, Q., Li, Q., Wu, H., & Bai, H. (2010) · Human Reproduction · doi:10.1093/humrep/deq047 · Cited by 87
Munir, I., Yen, H.-W., Baruth, T., Tarkowski, R., Azziz, R., Magoffin, D. A., & Jakimiuk, A. J. (2005) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2004-2152 · Cited by 86
Variation in Resistin Gene Promoter Not Associated With Polycystic Ovary Syndrome
Urbanek, M., Du, Y., Silander, K., Collins, F. S., Steppan, C. M., Strauss, J. F., Dunaif, A. E., Spielman, R. S., & Legro, R. S. (2003) · Diabetes · doi:10.2337/diabetes.52.1.214 · Cited by 85
Self-citationCardiometabolic features of polycystic ovary syndrome
Hoffman, L., & Ehrmann, D. A. (2008) · Nature Clinical Practice Endocrinology & Metabolism · doi:10.1038/ncpendmet0755 · Cited by 85
The physiological basis of complementary and alternative medicines for polycystic ovary syndrome
Raja-Khan, N. T., Stener‐Victorin, E., Wu, X., & Legro, R. S. (2011) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00667.2010 · Cited by 88
Self-citationEndometrial cancer in young, normal-weight women
Schmeler, K. M., Soliman, P. T., Sun, C. C., Slomovitz, B. M., Gershenson, D. M., & Lu, K. H. (2005) · Gynecologic Oncology · doi:10.1016/j.ygyno.2005.06.029 · Cited by 82
The Physiology and Pathology of the Female Reproductive Axis
Bulun, S. E., Adashi, E. Y., & Bulun, S. E. (2007) · Time to knit · doi:10.1016/b978-1-4160-2911-3.50018-2 · Cited by 84
Fux Otta, C., Wior, M., Iraci, G. S., Kaplan, R., Torres, D., Gaido, M. I., & Wyse, E. P. (2010) · Gynecological Endocrinology · doi:10.3109/09513590903215581 · Cited by 85
Agrawal, R., Sharma, S., Bekir, J. S., Conway, G. S., Bailey, J., Balen, A. H., & Prelević, G. M. (2004) · Fertility and Sterility · doi:10.1016/j.fertnstert.2004.04.041 · Cited by 83
Papadakis, G. E., Kandaraki, E., Tseniklidi, E., Papalou, O., & Diamanti‐Kandarakis, E. (2019) · Frontiers in Endocrinology · doi:10.3389/fendo.2019.00388 · Cited by 86
Jakubowicz, D. J., Essah, P. A., Seppälä, M. T., Jakubowicz, S., Baillargeon, J., Koistinen, R. A., & Nestler, J. E. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-030975 · Cited by 84
Siemińśka, L., Marek, B., Kos‐Kudła, B., Niedziolka, D., Kajdaniuk, D., Nowak, M., & Głogowska-Szeląg, J. (2004) · Journal of Endocrinological Investigation · doi:10.1007/bf03347474 · Cited by 85
Ghrelin in Diabetes and Metabolic Syndrome
Pulkkinen, L., Ukkola, O. H., Kolehmainen, M., & Uusitupa, M. I. J. (2010) · International Journal of Peptides · doi:10.1155/2010/248948 · Cited by 84
Polycystic Ovary Syndrome, Obesity and Reproductive Implications
Hirschberg, A. L. (2009) · Women s Health · doi:10.2217/whe.09.39 · Cited by 85
Metabolic syndrome in young Czech women with polycystic ovary syndrome
Vrbíková, J., Vondra, K., Cibula, D., Dvořáková, K., Stanická, S., Šrámková, D., Šindelka, G., Hill, M., Bendlová, B., & Škrha, J. (2005) · Human Reproduction · doi:10.1093/humrep/dei221 · Cited by 83
Emerging role of testosterone in pancreatic β cell function and insulin secretion
Xu, W., Morford, J. J., & Mauvais‐Jarvis, F. (2019) · Journal of Endocrinology · doi:10.1530/joe-18-0573 · Cited by 86
The optimal diet for women with polycystic ovary syndrome?
Marsh, K. A., & Brand-Miller, J. C. (2005) · British Journal Of Nutrition · doi:10.1079/bjn20051475 · Cited by 79
Insulin Sensitivity after Metformin Suspension in Normal-Weight Women with Polycystic Ovary Syndrome
Palomba, S., Falbo, A. I., Russo, T., Manguso, F., Tolino, A., Zullo, F., Feo, P. D., & Orio, F. (2007) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2007-0441 · Cited by 80
Endocrine and Metabolic Effects of Rosiglitazone in Non-obese Women with Polycystic Ovary Disease
Dereli, D., Dereli, T., Bayraktar, F., Özgen, G., & Yılmaz, C. (2005) · Endocrine Journal · doi:10.1507/endocrj.52.299 · Cited by 81
Yılmaz, M., Bukan, N. C., Ersoy, R., Karakoç, A., Yetkin, İ., Ayvaz, G., Çakır, N., & Arslan, M. (2005) · Human Reproduction · doi:10.1093/humrep/dei070 · Cited by 81
Incretin levels in polycystic ovary syndrome
Vrbikova, J., Hill, M., Bendlova, B., Grimmichova, T., Dvorakova, K., Vondra, K., & Pacini, G. (2008) · European Journal of Endocrinology · doi:10.1530/eje-08-0097 · Cited by 81
Lin, K., Sun, X., Wang, X., Wang, H., & Chen, X. (2021) · Frontiers in Endocrinology · doi:10.3389/fendo.2020.537809 · Cited by 81
The Lipid Accumulation Product Is Associated with Impaired Glucose Tolerance in PCOS Women
Wehr, E., Gruber, H., Giuliani, A., Möller, R., Pieber, T. R., & Obermayer-Pietsch, B. M. (2011) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2011-0031 · Cited by 79
Baldani, D. P., Škrgatić, L., & Ougouag, R. (2015) · International Journal of Endocrinology · doi:10.1155/2015/786362 · Cited by 85
Jakubowicz, D., Barnea, M., Wainstein, J., & Froy, O. (2013) · Clinical Science · doi:10.1042/cs20130071 · Cited by 81
Androgen Excess in Pancreatic β Cells and Neurons Predisposes Female Mice to Type 2 Diabetes
Navarro, G., Allard, C., Morford, J. J., Xu, W., Liu, S., Molinas, A. J. R., Butcher, S. M., Fine, N. H. F., Blandino-Rosano, M., Sure, V. N., et al. (2018) · JCI Insight · doi:10.1172/jci.insight.98607 · Cited by 80
Long term complications of polycystic ovary syndrome (PCOS)
Peigné, M., & Dewailly, D. (2014) · Annales d Endocrinologie · doi:10.1016/j.ando.2014.07.111 · Cited by 81
Influence of ethnicity on different aspects of polycystic ovary syndrome: a systematic review
Şendur, S. N., & Yıldız, B. O. (2020) · Reproductive BioMedicine Online · doi:10.1016/j.rbmo.2020.12.006 · Cited by 80
Insulin Sensitivity and β-Cell Function in Women With Polycystic Ovary Syndrome
Vrbíková, J., Bendlová, B., Hill, M., Vaňková, M., Vondra, K., & Stárka, L. (2002) · Diabetes Care · doi:10.2337/diacare.25.7.1217 · Cited by 81
Insulin-Lowering Drugs In Polycystic Ovary Syndrome
Iuorno, M. J., & Nestler, J. E. (2001) · Obstetrics and Gynecology Clinics of North America · doi:10.1016/s0889-8545(05)70191-1 · Cited by 79
Obesity and Lifestyle Management in Polycystic Ovary Syndrome
Hoeger, K. M. (2007) · Clinical Obstetrics & Gynecology · doi:10.1097/grf.0b013e31802f54c8 · Cited by 79
Kamenov, Z. A., Kolarov, G., Gateva, A., Carlomagno, G., & Genazzani, A. D. (2014) · Gynecological Endocrinology · doi:10.3109/09513590.2014.964640 · Cited by 80
Jamil, A. S., Alalaf, S., Al-Tawil, N. G., & Al‐Shawaf, T. (2015) · Reproductive Health · doi:10.1186/1742-4755-12-7 · Cited by 86
Epidemiology and Comorbidities of Polycystic Ovary Syndrome in an Indigent Population
Sirmans, S. M., Parish, R. C., Blake, S., & Wang, X. (2014) · Journal of Investigative Medicine · doi:10.1097/01.jim.0000446834.90599.5d · Cited by 79
Ovarian Hypertension: Polycystic Ovary Syndrome
Bentley–Lewis, R., Seely, E. W., & Dunaif, A. E. (2011) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/j.ecl.2011.01.009 · Cited by 83
Self-citationDemirel, F., Bıdecı, A., Cınaz, P., Çamurdan, M. O., Biberoğlu, G., Yeşilkaya, E., & Hasanoğlu, A. (2007) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2007.02849.x · Cited by 78
Xu, Y., Wu, Y., & Huang, Q. (2017) · Archives of Gynecology and Obstetrics · doi:10.1007/s00404-017-4480-z · Cited by 76
Role of Metformin in Polycystic Ovary Syndrome (PCOS): Related Infertility
Attia, G. M., Almouteri, M. M., & Alnakhli, F. T. (2023) · Cureus · doi:10.7759/cureus.44493 · Cited by 100
Stovall, D. W., Bailey, A. P., & Pastore, L. M. (2010) · Journal of Women s Health · doi:10.1089/jwh.2010.2053 · Cited by 77
Cardiovascular risk factors in young Czech females with polycystic ovary syndrome
Vrbíková, J. (2003) · Human Reproduction · doi:10.1093/humrep/deg218 · Cited by 77
Long term health consequences of polycystic ovarian syndrome: a review analysis.
Daniilidis, A., & Dinas, K. D. (2009) · Europe PMC (PubMed Central) · Cited by 77
Gambineri, A., Vicennati, V., Genghini, S., Tomassoni, F., Pagotto, U., Pasquali, R., & Walker, B. R. (2006) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2005-2222 · Cited by 75
Dixon, J. B., & O’Brien, P. E. (2002) · Clinical Endocrinology · doi:10.1046/j.1365-2265.2002.01665.x · Cited by 75
Celik, C., Taşdemir, N., Abalı, R., Baştu, E., & Yılmaz, M. (2014) · Fertility and Sterility · doi:10.1016/j.fertnstert.2013.12.050 · Cited by 74
Polycystic ovary syndrome: A review for dermatologists
Housman, E., & Reynolds, R. V. (2014) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2014.05.007 · Cited by 78
Wu, Y., Zhang, J., Wen, Y., Wang, H., Zhang, M., & Cianflone, K. (2008) · Fertility and Sterility · doi:10.1016/j.fertnstert.2007.11.031 · Cited by 74
Powell, B. L., Haddad, L., Bennett, A. J., Gharani, N., Sovio, U., Groves, C. J., Rush, K., Goh, M. J., Conway, G. S., Ruokonen, A., et al. (2005) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2004-2485 · Cited by 76
Steroidogenesis—Adrenal Cell Signal Transduction
Gallo‐Payet, N., & Battista, M. (2014) · Comprehensive physiology · doi:10.1002/cphy.c130050 · Cited by 87
Lerchbaum, E., Schwetz, V., Giuliani, A., & Obermayer-Pietsch, B. (2013) · Human Reproduction · doi:10.1093/humrep/det255 · Cited by 73
The Relationship Between Polycystic Ovary Syndrome and Antiepileptic Drugs
Rasgon, N. (2004) · Journal of Clinical Psychopharmacology · doi:10.1097/01.jcp.0000125745.60149.c6 · Cited by 73
Korhonen, S. (2003) · Human Reproduction · doi:10.1093/humrep/deg128 · Cited by 73
Neuroendocrine consequences of androgen excess in female rodents
Foecking, E. M., McDevitt, M. A., Acosta‐Martínez, M., Horton, T. H., & Levine, J. E. (2008) · Hormones and Behavior · doi:10.1016/j.yhbeh.2007.12.013 · Cited by 73
Ujvari, D., Hulchiy, M., Calaby, A., Nybacka, A., Bystrom, B., & Hirschberg, A. L. (2014) · Human Reproduction · doi:10.1093/humrep/deu114 · Cited by 72
Geller, D. H., Pacaud, D., Gordon, C. M., & Misra, M. (2011) · International Journal of Pediatric Endocrinology · doi:10.1186/1687-9856-2011-9 · Cited by 72
O’Reilly, M. W., Glisic, M., Kumarendran, B., Subramanian, A., Manolopoulos, K. N., Tahrani, A. A., Keerthy, D., Muka, T., Toulis, K. A., Hanif, W., et al. (2019) · Clinical Endocrinology · doi:10.1111/cen.13862 · Cited by 72
Moret, M., Stettler, R., Rodieux, F., Gaillard, R. C., Waeber, G., Wirthner, D., Giusti, V., Tappy, L., & Pralong, F. P. (2009) · Neuroendocrinology · doi:10.1159/000160911 · Cited by 72
Polycystic Ovarian Syndrome: Long-Term Health Consequences
Zore, T., Joshi, N., Lizneva, D., & Azziz, R. (2017) · Seminars in Reproductive Medicine · doi:10.1055/s-0037-1603096 · Cited by 72
Implicating androgen excess in propagating metabolic disease in polycystic ovary syndrome
Kempegowda, P., Melson, E., Manolopoulos, K. N., Arlt, W., & O’Reilly, M. (2020) · Therapeutic Advances in Endocrinology and Metabolism · doi:10.1177/2042018820934319 · Cited by 78
Baillargeon, J., & Carpentier, A. C. (2007) · Diabetologia · doi:10.1007/s00125-007-0831-9 · Cited by 72
Penna, I. A. A., Canella, P. R. B., dos Reis, R. M., de Sá, M. F. S., & Ferriani, R. A. (2005) · Human Reproduction · doi:10.1093/humrep/dei104 · Cited by 72
Stadtmauer, L. A. (2002) · Human Reproduction · doi:10.1093/humrep/17.12.3016 · Cited by 73
Aroda, V. R., Ciaraldi, T. P., Burke, P., Mudaliar, S., Clopton, P., Phillips, S., Chang, R. J., & Henry, R. R. (2009) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2008-1133 · Cited by 71
Letrozole Rat Model Mimics Human Polycystic Ovarian Syndrome and Changes in Insulin Signal Pathways
Xu, J., Dun, J., Yang, J., Zhang, J., Lin, Q., Huang, M., Ji, F., Huang, L., You, X.-M., & Lin, Y. (2020) · Medical Science Monitor · doi:10.12659/msm.923073 · Cited by 76
McGee, W., Bishop, C., Bahar, A., Pohl, C., Chang, R., Marshall, J., Pau, F., Stouffer, R., & Cameron, J. (2012) · Human Reproduction · doi:10.1093/humrep/der393 · Cited by 71
Metabolic complications of obesity
Pedersen, S. D. (2013) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2013.02.004 · Cited by 75
Metadata
- Authors
- Legro, R. S.
- Affiliations
- Pennsylvania State University (US)
- ORCID
- Legro, R. S.
- Venue
- Journal of Clinical Endocrinology & Metabolism
- Publisher
- The Endocrine Society
- Published
- 1999-01-01
- Volume
- 84
- Issue
- 1
- Pages
- 165-169
- ISSN
- 0021-972X (ISSN-L)
- OpenAlex
- W2096126402
- Cited by
- 1,743
- References
- 0
- Citations by year
- 2026: 16 · 2025: 25 · 2024: 36 · 2023: 24 · 2022: 50 · 2021: 64 · 2020: 54 · 2019: 42 · 2018: 43 · 2017: 66 · 2016: 59 · 2015: 88 · 2014: 81 · 2013: 73 · 2012: 84
- FWCI
- 44.44
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- cc-by
- Locations
- The Journal of Clinical Endocrinology & Metabolism (publishedVersion, cc-by)
- The Journal of Clinical Endocrinology & Metabolism (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institute of Diabetes and Digestive and Kidney Diseases (R01DK040605)
- Eunice Kennedy Shriver National Institute of Child Health and Human Development (K08 HD-O118, U54HD034449)
- Topics
- Health Sciences › Medicine › Reproductive Medicine › Ovarian function and disorders
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Health Sciences › Medicine › Obstetrics and Gynecology › Gestational Diabetes Research and Management
- Keywords
- polycystic ovary syndrome, type 2 diabetes, impaired glucose tolerance, insulin resistance, insulin secretion, diabetes risk factors, prevalence, fasting blood glucose, waist-to-hip ratio, body mass index, ethnic differences, diagnostic criteria, underdiagnosis, oral glucose tolerance test, young women, obesity
- MeSH terms
- Adolescent, Adult, Blood Glucose, Diabetes Mellitus, Type 2, Female, Glucose Tolerance Test, Humans, Insulin Resistance, Polycystic Ovary Syndrome, Prospective Studies, Risk, Body Mass Index, Prevalence
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
